BioLargo, Inc. BLGO
0.08 USD 0.00 (+4.00%)
Nov 5, 2026, 2:58 PM EST
0.0701 Day range 0.082
0.06 52-week range 0.20
- YTD
- -56.67%
- 1 year
- -51.25%
- Market cap
- 26.10M
- EPS (ttm)
- -0.05
- YTD return
- -56.67%
- 1-year return
- -51.25%
- Volume
- 432.07K
- Avg volume
- 404.43K
- Open
- 0.0778
- Previous close
- 0.075
- Day's range
- 0.0701 – 0.082
- 52-week range
- 0.06 – 0.20
5D +0.0150 (+23.08%)
News
BioLargo Subsidiary Clyra Medical to Exhibit at SAWC Fall 2026 in Las Vegas 
BioLargo, Inc. (BLGO) Q2 2026 Earnings Call Transcript 
BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More 
BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time 
BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution 
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026 
Critical Review: BioLargo (NASDAQ:BLGO) and Akzo Nobel (OTCMKTS:AKZOD) 
BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York 
Gabelli To Host 4th Annual PFAS Symposium 
BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
Your note
Sign in to keep a note on BLGO — it syncs with the Stock Master app.